Ju-Ming Wang Selected Research

CCAAT-Enhancer-Binding Protein-delta

12/2021	Biological significance of MYC and CEBPD coamplification in urothelial carcinoma: Multilayered genomic, transcriptional and posttranscriptional positive feedback loops enhance oncogenic glycolysis.
1/2021	CCAAT/Enhancer-binding protein delta mediates glioma stem-like cell enrichment and ATP-binding cassette transporter ABCA1 activation for temozolomide resistance in glioblastoma.
1/2020	Metformin Resensitizes Sorafenib-Resistant HCC Cells Through AMPK-Dependent Autophagy Activation.
1/2018	Astrocytic CCAAT/Enhancer-binding protein delta contributes to reactive oxygen species formation in neuroinflammation.
11/2017	Bortezomib-induced miRNAs direct epigenetic silencing of locus genes and trigger apoptosis in leukemia.
9/2017	CCAAT/enhancer-binding protein delta promotes intracellular lipid accumulation in M1 macrophages of vascular lesions.
2/2017	Metformin promotes apoptosis in hepatocellular carcinoma through the CEBPD-induced autophagy pathway.
11/2016	Astrocytic CCAAT/Enhancer-Binding Protein Delta Contributes to Glial Scar Formation and Impairs Functional Recovery After Spinal Cord Injury.
11/2015	HMDB and 5-AzadC Combination Reverses Tumor Suppressor CCAAT/Enhancer-Binding Protein Delta to Strengthen the Death of Liver Cancer Cells.
9/2015	Targeting chemotherapy-induced PTX3 in tumor stroma to prevent the progression of drug-resistant cancers.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ju-Ming Wang Research Topics

Disease

25	Neoplasms (Cancer) 01/2022 - 11/2008
8	Neoplasm Metastasis (Metastasis) 01/2022 - 07/2009
6	Inflammation (Inflammations) 01/2021 - 07/2009
4	Leukemia 01/2021 - 12/2013
4	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 11/2008
4	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 01/2014
3	Carcinoma (Carcinomatosis) 12/2021 - 08/2010
2	Liver Neoplasms (Liver Cancer) 01/2020 - 11/2015
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2015 - 07/2005
2	Amyloid Plaque 02/2015 - 01/2014
2	Breast Neoplasms (Breast Cancer) 01/2013 - 01/2012
2	Carcinogenesis 02/2012 - 10/2010
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2010 - 11/2008
1	Chronic Renal Insufficiency 04/2022
1	Triple Negative Breast Neoplasms 01/2022
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 12/2021
1	Glioma (Gliomas) 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 01/2021
1	Brain Neoplasms (Brain Tumor) 01/2021
1	Gallbladder Neoplasms (Gallbladder Cancer) 01/2021
1	Hypoxia (Hypoxemia) 10/2019
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2019
1	Neuroinflammatory Diseases 01/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2017
1	Atherosclerotic Plaque (Atheroma) 09/2017
1	Spinal Cord Injuries (Spinal Cord Injury) 11/2016
1	Gliosis 11/2016
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2016
1	Infections 01/2016
1	Squamous Cell Carcinoma of Head and Neck 04/2015
1	Head and Neck Neoplasms (Head and Neck Cancer) 04/2015
1	Esophageal Neoplasms (Esophageal Cancer) 09/2014
1	Esophageal Squamous Cell Carcinoma 09/2014
1	Nasopharyngeal Carcinoma 07/2013
1	Rheumatoid Arthritis 01/2012
1	Colorectal Neoplasms (Colorectal Cancer) 10/2011
1	Genomic Instability 08/2011
1	Aneuploidy (Aneuploid) 08/2011

Drug/Important Bio-Agent (IBA)

21	CCAAT-Enhancer-Binding Protein-deltaIBA 12/2021 - 07/2005
10	Proteins (Proteins, Gene)FDA Link 01/2020 - 10/2010
8	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2012
4	Pharmaceutical PreparationsIBA 05/2021 - 09/2015
4	CCAAT-Enhancer-Binding ProteinsIBA 10/2019 - 07/2013
4	CytokinesIBA 06/2019 - 11/2008
3	Cisplatin (Platino)FDA LinkGeneric 01/2017 - 08/2010
3	Messenger RNA (mRNA)IBA 01/2016 - 11/2008
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016 - 08/2011
3	ErbB Receptors (EGF Receptor)IBA 09/2015 - 02/2012
3	Epidermal Growth Factor (EGF)IBA 04/2015 - 07/2005
2	IonsIBA 04/2022 - 09/2015
2	PTX3 proteinIBA 01/2022 - 07/2013
2	Biological ProductsIBA 12/2021 - 01/2015
2	Metformin (Glucophage)FDA LinkGeneric 01/2020 - 02/2017
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 04/2015 - 01/2010
1	PotassiumIBA 04/2022
1	Complement System Proteins (Complement)IBA 12/2021
1	Glucose (Dextrose)FDA LinkGeneric 12/2021
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 10/2021
1	Temozolomide (Temodar)FDA LinkGeneric 01/2021
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2021
1	Gemcitabine FDA Link 01/2021
1	LeptinIBA 01/2021
1	AMP-Activated Protein KinasesIBA 01/2020
1	Sorafenib (BAY 43-9006)FDA Link 01/2020
1	hepatoma-derived growth factorIBA 10/2019
1	Extracellular Matrix ProteinsIBA 10/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	Bortezomib (Velcade)FDA Link 11/2017
1	MicroRNAs (MicroRNA)IBA 11/2017
1	Apolipoproteins E (ApoE)IBA 09/2017
1	LipidsIBA 09/2017
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2017
1	Toll-Like Receptor 3IBA 01/2016
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2016
1	Decitabine FDA Link 11/2015
1	Fluorouracil (Carac)FDA LinkGeneric 09/2015
1	Peptides (Polypeptides)IBA 09/2015
1	Cadherins (E-Cadherin)IBA 04/2015
1	Fibronectins (Fibronectin)IBA 04/2015
1	Thrombospondin 1IBA 03/2015
1	Insulin-Like Growth Factor Binding Protein 3IBA 02/2015
1	Promyelocytic Leukemia Zinc Finger ProteinIBA 02/2015
1	Protein Isoforms (Isoforms)IBA 09/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2014
1	Amyloid (Amyloid Fibrils)IBA 01/2014
1	Conditioned Culture MediaIBA 07/2013
1	ELAV-Like Protein 1IBA 07/2013
1	Interleukin-10 (Interleukin 10)IBA 07/2013
1	src-Family KinasesIBA 01/2012
1	Matrix Metalloproteinases (MMPs)IBA 01/2012
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2012
1	Tyrosine (L-Tyrosine)FDA Link 01/2012
1	Peptide Hydrolases (Proteases)FDA Link 01/2012
1	CollagenIBA 01/2012
1	Aurora Kinase CIBA 08/2011

Therapy/Procedure

5	Therapeutics 01/2022 - 12/2010
3	Drug Therapy (Chemotherapy) 05/2021 - 08/2010
1	Precision Medicine 12/2021
1	Radiotherapy 01/2021
1	Combination Drug Therapy (Combination Chemotherapy) 01/2017